Navigation Links
Canada May Not Permit Bextra To Reenter Market

Health Canada has announced a ban on the anti-inflammatory drug Bextra, meant for those who suffer from arthritis. The benefits derived from the drug were outweighed by the cardiovascular risks, including the possibility of // triggering strokes and heart attacks, according to an expert safety panel.

The drug is also known to cause severe skin reactions which can even prove to be fatal. Pfizer had earlier withdrawn the drug which belongs to the cox-2 inhibitors class after incidences of skin reactions in the country. Pfizer Canada however is of the view that the drug should be made available to those who continue to benefit from it.

The regulators in Europe and Canada have also voiced strong objections to the drug, as its safety is under doubt. The total sales Bextra in 2004 across the world was at US$ 1.3 billion. Vioxx, manufactured Merck & Co. Inc was also withdrawn from the market for similar reasons. This drug however has a chance of being permitted to enter the Canadian market again.
'"/>




Page: 1

Related medicine news :

1. Canada stunned as mad cow discovery leads to beef ban
2. Canada withdraws ADHD drug Adderall XR
3. Canada helps in giving birth to world first baby from frozen egg
4. Ban On Indian Ayurvedic Drugs In Canada
5. Polio Fears Raised In Canada
6. Long wait for Chronic pain patients in Atlantic Canada
7. Bird flu virus isolated from duck farm in Canada
8. Canada Needs More Doctors To Deal With A Pandemic
9. Canada Introduces Mandatory Nutrition Labeling
10. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
11. Canadian Sikh Community Donates To Hospital Project In Canada

Post Your Comments:
(Date:11/23/2009)...,, CARLSBAD,Calif.,Nov.23/PRNewswire-FirstCa..., Iwouldliketostartbythankingyouforyourcontinuing...ulmomentsinourhistory.Wearetrulyattheendofthebegin...yplatform,whichwebelieveaddressesmanyoftheissuesha...ispredicatedlargelyuponthesuccessofourflagshipdrug...
(Date:11/23/2009)...,, SANDIEGO,Calif.,Nov.23/PRNewswire-FirstCa...)todayannouncedthatfourseniorexecutiveshavejoinedt...sdrivingthedevelopmentofitsobesityfranchise.Additi...dofGlobalRegulatoryAffairs;SuzanneMcDonald,HeadofM....D.,HeadofGlobalContraveProgram;andWhedyWang,Ph.D,...
(Date:11/23/2009)..., Baptist Cardiovascular ...Jackson, Miss., is proud to announce the addition ... to its latest advancement in the treatment of pat... and clinicians breathe easier. , ...-- For heart failure patients suffering from fluid...
(Date:11/23/2009)...,, NORTHANDOVER,Mass.,Nov.23/PRNewswire/--Th...stressandanxiety.Oftenthesefeelings,bothpositivean...g;andlet,sfaceit,therearelotsofopportunitiestodoso...eonepieceofmom,sapplepie,buthowmanyofusstopthere?"...ushavespentholidayseasonafterholidayseasontellingo...
(Date:11/23/2009)..., Summary: People are hir...sonalities. Personality assessments give insight i...formance. The Candidate Potential Report assesses ... summarizes the recommendation for job fit and pot...aybrook, CT (PRWEB) November 23, 2009 -- When does...
Breaking Medicine News(10 mins):Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 2Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 4Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 5Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 2Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 3Health News:Tis' the Season to Eat and Eat More! 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 3
... at University of Heidelberg in Mannheim, conclude...age more rapidly than men.// The study also states...quently as men do. This will have a revolut...d before pregnancy. It might have adverse effects ...
...ve shown that daily oral doses of Lorenzos oil can...gical disorder// called X-linked adrenoleukodystro...r Institute in Baltimore have reported that use of...e their daily doses of the oil, which is a composi...
... Drug Administration is scrutinizing the claims m...tion Bio- Germ .According to the claims made by th... can give protection from anthrax . The Bio-Germ P...ch is made from grapefruit seeds and the oil of an...
...en found to reduce the risk of cellular rejection ...ndard immunosuppression. The drug, a humanize...erleukin-2 receptor, thereby inhibiting T-cell pro...te or severe cellular rejection, hemodynamically s...
...rm of ancient Indian exercise and meditation for t...ng properties and is popularly used to relieve peo...n, trauma and anxiety in patients with breast can...ive outcome to relieve patients of pain. Now The U...
...ional study was done involving 598 068 nuclear ind...one to estimate the risk of cancer after administr...n international collaborative study to estimate th... study recruits were employed in 154 different fac...
Other Medicine News:Health News:A New Product Offering protection against anthrax 2Health News:Yoga Can Be Good For Breast Cancer Patients 2Health News:Cancer risk among nuclear industry workers 2
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall...ced results for its first quarter ended September ...er diluted share, on revenues of $3,263,000. This...r diluted share, on revenues of $3,168,000 for the...he first quarter results, Biotel President and CEO...
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , ARDEE, Ireland, Nov. 19 ...ed the pricing of its previously announced seconda...t a price to the public of $22.25 per share. The ... Bain Capital Partners, DLJ Merchant Banking, J.P....mas H. Lee Partners, L.P., certain other instituti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5Alcohol advertising self regulation not working as ads target younger drinkers 48311 1Alcohol advertising self regulation not working as ads target younger drinkers 48311 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2
...uticals, Inc.,announced today that a new analysis ... Biomedical Research Institute at Harbor-UCLA Medi...of hypogonadal men with AndroGel(R),(testosterone ...rdless of,weight and body mass index (BMI). These ...ocrine Society Annual Meeting (ENDO) in San Franci...
...ONE MINERAL DENSITY, SAN DIEGO, June 17 Neurocri...ay that the elagolix 0603 Phase IIb trial,(Petal S...he last subject,completed her Week 24 study visit ...mpact of elagolix treatment on bone mineral densit...X-ray Absorptiometry (DXA) scans to,document any c...
Other Medicine Technology:New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 2New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 3New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 4Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 2Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 3
Semi-rigid biopsy forceps
Cup Biopsy Forceps
Unitized Electric Reciprocating Saw, w/ Hand Throttle
Unitized Electric Sagittal Saw, Throttleless
Medicine Products: